A Leader in the Design of Small Molecule Therapeutics that Target Protein-Protein Interactions

Ascentage is a globally-focused clinical-stage biopharmaceutical company developing first- and best-in-class targeted therapeutics for cancers, hepatitis B & age-related diseases.

  • 3

    Distinct Apoptosis Targets

  • 7

    Product Candidates in Clinical Development

  • 20

    Years in PPI Apoptosis Research